Search Follow us

Simavita (SVA)

Business description

Simavita listed on TSX-V in Dec 2013 and ASX in Feb 2014. Its SIM platform technology is an integrated assessment device that helps manage urinary incontinence. The devices are used in residential and nursing home settings to optimise incontinence care.

Termination of coverage

Update | Pharmaceutical & healthcare | 22/06/2015

Edison Investment Research is terminating coverage on Simavita (SV/SVA). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Edison's research is freely available. We will never ask for your credit card details and you do not need to register. By downloading this research you are agreeing to our terms and conditions, which you can read in full here.

Stock data

Market cap.A$2.6m
Last closeA$0.022
High / Low (52 weeks)A$0.1 / A$0.0
Stock market listingAU
Forecast net cash (A$m)10.1
Forecast gearing ratio (%)N/A
TeamHealthcare
SectorPharmaceutical & healthcare

Price performance

%1m3m12m
Actual(4.3)(26.7)(56.2)
Relative *(5.4)(27.6)(58.3)

* % Relative to local index

Company news